# Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?

> **NCT00851175** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 8 (estimated)

## Conditions studied

- Atherosclerosis
- Cardiovascular Disease

## Interventions

- **DRUG:** rosuvastatin
- **DRUG:** caffeine

## Key facts

- **NCT ID:** NCT00851175
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2009-08
- **Final completion:** 2009-09
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2009-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00851175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00851175, "Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00851175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*